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Introduction: To determine whether a simple, structured self-report of overall 
sleep quality is associated with the presence of the metabolic syndrome and its 
components. 
Methods: An observational, cross-sectional study comparing global score on 
the Pittsburgh Sleep Quality Index (PSQI) with concurrently collected 
measures of the components of the metabolic syndrome and presence or 
absence of the syndrome. A total of 3,057 adults, aged 18 - 80, who visited the 
Center for Health Promotion of Seoul National University Hospital in Korea 
between January 2010 and December 2011, were included in this study. The 
sample included 2,076 males (67.9%) and 981 females (32.1%). The prevalence 
of metabolic syndrome in our sample was 21.5% (27.0% for males and 10.0% 
for females). The subjects were divided into two groups of poor sleeper group 
(n = 529) vs. good sleeper group (n = 2,528) by the Pittsburgh Sleep Quality 
Index global score. The components of metabolic syndrome, serum levels of 
insulin and abdominal computed tomography (CT) scans were measured. The 
metabolic syndrome criterion of the AHA/NHLBI 2005 was adopted. All 
analyses were adjusted for age, education, alcohol, smoking, stress, anxiety, 
depression, physical activity, snoring and use of hypertensive drugs. 
Results: Logistic regression results showed that global sleep-quality score on 
the PSQI were not related significantly to the presence of the metabolic 
syndrome (OR = 1.07, 95% CI: 0.79 - 1.44 for males; OR = 1.16, 95% CI: 0.66 
– 2.02 for females). The multiple-regression results showed that the PSQI 
global sleep-quality score was not related to abdominal visceral fat, insulin 
levels, insulin resistance and most metabolic syndrome components 
significantly. However, poor sleep quality was related to high-density 
lipoprotein (p = 0.014) positively among males, and the predictor of waist 
circumference (p < 0.001) and body mass index (p = 0.009) gain among females. 
Conclusions: In conclusion, self-reported global sleep quality is not related to 
metabolic syndrome and most its risk factor components. However, obesity is 
associated with poor sleep quality in women. Additional prospective cohort 
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studies are needed to evaluate relationships among these measures, the 
behavioral and physiologic mechanisms that link sleep quality and metabolic 
disorders. 
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Metabolic syndrome represents a cluster of coronary heart disease risk factors, 
including obesity (particularly abdominal adipose tissue), elevated blood 
pressure, high fasting plasma glucose and triglyceride concentrations, and low 
serum high-density lipoprotein cholesterol levels (1). The importance of central 
obesity and abdominal fat mass has been known to have a stronger relation to 
the prevalence of each component of metabolic syndrome (hyperglycemia, 
diabetes and hypertension) than body mass index (BMI) (2). Increased insulin 
levels and insulin resistance are defined by some as part of the metabolic 
syndrome but are considered by others as an underlying cause for the syndrome 
(3-6). When initially identified, the clustering of these risk factors was thought 
to be induced by dysregulation of insulin (3). However, the pathophysiologic 
basis of the metabolic syndrome remains in doubt (7,8). Indeed, some have 
questioned the clinical value of identifying the syndrome despite the 
associations between the syndrome and disease incidence (6). 
Chronic sleep debt, which is increasingly common in developed countries, is 
associated with metabolic and endocrine alterations that may have pathological 
consequences in the long term (9,10). Regarding sleep duration, both short and 
long are associated with metabolic syndrome (11-13). In addition to sleep 
duration, Jennings et al. showed that the low sleep quality is associated with 
metabolic syndrome in a sample of two hundred and ten Caucasian adults (14). 
A Taiwanese study has showed that subjects who have higher global PSQI score 
and a higher risk of being poor sleepers are more likely to relate to metabolic 
syndrome (15). Reduced sleep quality without changes in duration is associated 
with insulin resistance (16,17) and sleep disturbances are also related to 
diabetes (18) and all-cause mortality (19). Despite these associations, not all 
studies have found sleep disruption and metabolic disease to be related. For 
example, one recent report failed to find a relationship between sleep 
disturbance in midlife in women and subsequent incidence of diabetes (20). In 
the Coronary Artery Risk Development in Young Adults Sleep Study, both 
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shorter sleep duration and greater sleep fragmentation were not with markers 
of glucose metabolism in non-diabetic middle-aged adults (21). 
The Pittsburgh Sleep Quality Index (PSQI) is a widely used and well-validated 
measure of sleep quality, and is suitable for epidemiologic investigations 
(22,23). There are limited studies that explore whether the PSQI sleep quality 
is related to computed tomography (CT) abdominal fat, insulin resistance and 
metabolic syndrome in a large sample study. The objective of this study was 
therefore to examine the relationship between sleep quality and metabolic 
syndrome in 3,057 Korean people, who were examined with CT scanning of 
the abdomen and measured with fasting blood samples of insulin, which are 
valid biomarkers to understand the mechanism of metabolic disorders, using 























From January 2010 to December 2011, 10,727 subjects visited the Center for 
Health Promotion of Seoul National University Hospital for a routine health 
check-up. Exclusion criteria included clinical history of coronary artery disease, 
cerebrovascular diseases, cancer diagnosis or treatment within the past year, 
chronic liver or kidney disease, thyroid disease, pregnancy and weight-loss. 
The subjects, younger than 18 years or older than 80 years were also excluded. 
Of 3,682 participants who completed the PSQI and were identified the above 
exclusion criteria, 622 subjects were excluded because of not completing a 
structured questionnaire, which included marriage, education, job, income, 
smoking history, alcohol use, stress, anxiety, depression and physical activity. 
Three subjects, who had extreme data on high-density lipoprotein cholesterol 
(HDL-C) and diastolic blood pressure (DBP), or was missing of blood samples 
information, were excluded. Finally, this left data from 3,057 participants, aged 
18 to 80. The institutional review board of Seoul National University Hospital 
approved the study. 
 
2. Sleep-Quality Assessment 
 
The PSQI has been widely used and has good psychometric properties. The 
instrument, its reliability, and its validity are presented in Buysse et al (22). 
Nineteen items generate a global sleep-quality score, as well as score on 7 
components of sleep quality: subjective sleep quality, sleep latency, sleep 
duration, habitual sleep efficiency, sleep disturbances, use of sleeping 
medication, and daytime dysfunction. A higher global PSQI score indicates 
poorer sleep quality, and a global PSQI score greater than 8.5 has a diagnostic 
sensitivity of 94.3% and specificity of 84.4% in differentiating poor from good 
sleepers. The Korean version of the Pittsburgh Sleep Quality Index has an 
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overall reliability coefficient of 0.84, and acceptable test-retest reliability with 
a coefficient of 0.65 (23). 
 
3. Risk-Factor Assessments 
 
All subjects underwent physical examinations by trained personnel who used 
a written, systematic protocol with standardized instruments. Wearing light 
indoor clothes, each subject’s body height (to the nearest 0.1 cm), weight (to 
the nearest 0.1 kg), and waist circumference (to the nearest 0.1 cm) was 
measured. Waist circumference measurement was performed at the end of 
normal expiration in duplicate on bare skin midway between the lower rib 
margin and the iliac crest. BMI was calculated as weight (in kilograms) divided 
by height (in meters) squared. For blood pressure measurement, each subject 
rested 10 minutes in a supine position in a quiet ambience, and two 
measurements were obtained with an automated machine between 7:30 AM and 
11:00 AM. All subjects underwent 12-h overnight fasting and blood sampling 
for basic biochemical examinations, such as triglyceride, HDL-C, fasting blood 
sugar (FBS) and so on.  
Serum triglyceride, HDL-C, FBS and insulin were determined in the 
laboratory of Seoul National University Hospital. Insulin resistance was 
estimated from the homeostasis model assessment (HOMA-IR) = serum insulin 
(μIU/mL) × fasting blood glucose (mmol/L)/22.5 (24).  
Subjects were examined with a 16 detector row Somatom®  Sensation 16 CT 
scanner. CT was done between the fourth and fifth lumbar vertebrae. The cross-
sectional surface areas of the abdominal fat compartments (visceral adipose 
tissue and total adipose tissue) were calculated using Rapidia 2.8 CT software 
(Infinitt, Seoul, Korea) with attenuation ranging from -250 to -50 HI to separate 
fat tissue. Subcutaneous adipose tissue (SAT) area was obtained by subtracting 
visceral adipose tissue (VAT) from total adipose tissue. 
Metabolic syndrome was defined according to National Cholesterol 
Education Program (NCEP) criteria as the presence of three or more of the 
following five criteria (1). 
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[1] A waist circumference greater than 90 cm in males or greater than 80 cm in 
females; 
[2] A fasting serum glucose level of 100 mg/dL or higher or the use of diabetes 
medication; 
[3] A blood pressure of 130 mmHg systolic/85 mmHg diastolic or higher or the 
use of antihypertensive medication; 
[4] A serum triglyceride level of 150 mg/dL or higher or the use of medication 
for dyslipidemia 
[5] A high-density lipoprotein (HDL) cholesterol level of less than 40 mg/dL in 




At the time of health check-up, all subjects completed a self-administered 
questionnaire, which included questions about education, smoking history, 
alcohol use, stress, anxiety, depression, physical activity, menopause (female) 
and so on. Education was grouped into 3 categories, “less than high school,” 
“high school graduate,” and “more than high school.” Smoking history was 
categorized as nonsmoker, past smoker, and current smoker. For alcohol use, 
participants were asked if they were nondrinkers, past drinkers and current 
drinkers. BEPSI refers to Brief Encounter Psychosocial Instrument. Anxiety 
and depression were measured by Goldberg's short screening scale for anxiety 
and depression (25). Physical activity measured by the short last-seven-day 
self-administered format of the International Physical Activity Questionnaire 
(IPAQ) , which was grouped in to low, moderate and high (26). Snoring is 
defined as coughing or snoring loudly three times or more a week during the 
past month. Menopausal status was recorded as premenopausal, menopausal 




Our hypothesis is that the prevalence of metabolic syndrome among poor 
sleepers group is higher than good sleepers group. 
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Null hypothesis is that the prevalence of metabolic syndrome among poor 
sleepers group and good sleepers group is equal. 
Alternative hypothesis is that the prevalence of metabolic syndrome among 
poor sleepers group and good sleepers group is unequal. 
 According to prior data, if the prevalence of metabolic syndrome among good 
sleepers group is 0.22, the prevalence of metabolic syndrome among poor 
sleepers group is 0.30, and power is 0.8, we will need to study 962 subjects, 
which were enough to conduct an experiment for us using the stratified analysis 
by gender (15). 
According to the univariate analysis of sleep quality and metabolic syndrome, 
we select age, snoring, use of hypertensive drugs as confounders, which were 
statistical significant (P < 0.05). After controlling for menopausal status, the 
results were unchanged. In addition, for the limitation to include at least 962 
subjects to study, we did not select menopausal status as confounder, which has 
much missing data. Regarding to marriage status, job, income, which were 
partly associated with poor sleep quality and metabolic syndrome in the present 
study, we just take out them to analysis the baseline characteristics of subjects 
more clearly and deeply, for the reason that there were nearly no effects in the 
process of statistical model building. Because education, alcohol use, smoking 
history, stress, anxiety, depression, physical activity are associated with sleep 
quality and metabolic syndrome in the preceding studies (27 – 32), which 
showed statistical significant (P < 0.05) in parts of our study results, we also 
take them account into as confounders. More importantly, after controlling for 
these confounders, the statistical model became more reliant. 
The statistical model: 
Y= a0 + a1Xag + a2Xed + a3Xal + a4Xsm + a5Xst + a6Xax + a7Xdr + a8Xpi + a9Xsn 
+ a10Xuh 
ag = age, ed = education, al = alcohol, sm = smoking, st = stress, ax = anxiety, 
dr = depression, pi = physical activity, sn = snoring, uh = use of hypertensive 
drugs. 
Because triglycerides, FBS, HDL, insulin and HOMA data were skewed, the 
square root of a negative reciprocal, a negative reciprocal and logarithmic 
transformations were conducted separately. 
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We compared sleep quality and metabolic syndrome categories using t-test 
or chi-square test. The results are expressed as the mean (SD) or frequency (%). 
All statistical analyses were conducted separately for each gender. Continuous 
variables, including VAT, SAT, HOMA, Insulin were divided into subgroups. A 
logistic-regression analysis was performed using STATA software (version 11.2; 
STATA Corp, Houston, TX) with presence or absence of the metabolic 
syndrome as the dependent variable and the PSQI global sleep-quality score as 
the predictor variable, controlling for age, education, alcohol, smoking, stress, 
anxiety, depression, physical activity, snoring and use of hypertensive drugs. 
The same predictor was then used in a multiple-regression relating PSQI to VAT, 



























In this study, 17% of the current sample scored in the poor-sleeper range 
(global sleep-quality index > 8.5). Blood pressure and serum indexes were 
reasonably typical for healthy individuals in this age range. 21.5% of the 
participants met the criterion for the metabolic syndrome. 
Among males, poor sleep quality was related to marriage status (p < 0.001), 
alcohol use (p = 0.044), stress (p < 0.001), anxiety (p < 0.001), depression (p < 
0.001), and snoring (p < 0.001) positively in statistical significant. However, 
sleep quality is poorer in younger subjects among males (p = 0.001). In addition, 























Table 1A. Baseline characteristics of the subjects among males (n = 2,076). 
  Good sleeper 
global PSQI ≤ 5 
(n = 1,771) 
Poor sleeper 
global PSQI > 5 
(n = 305) 
 
P-value* 
Age (y)  51.92 ± 11.75  49.53 ± 12.66 0.001 
Marriage status   < 0.001 
  Yes 1,608 (86.4) 254 (13.6)  
  No  163 (76.2)  51 (23.8)  
Education   0.700 
< High School 138 (87.3) 20 (12.7)  
High School Graduate 378 (85.7) 63 (14.3)  
> High School 1,255 (85.0) 222 (15.0)  
Job†   0.022 
Group 1 537 (87.2) 79 (12.8)  
Group 2 409 (87.2) 60 (12.8)  
Group 3 467 (85.4) 80 (14.6)  
Group 4 199 (81.9) 44 (18.1)  
Group 5 159 (79.1) 42 (20.9)  
Income‡   0.890 
Group 1 516 (85.6) 87 (14.4)  
Group 2 731 (85.8) 121 (14.2)  
Group 3 466 (84.9) 83 (15.1)  
Alcohol use   0.044 
None 255 (89.2) 31 (10.8)  
Past 129 (89.0) 16 (11.0)  
Current 1,387 (84.3) 258 (15.7)  
Smoking   0.109 
Non-smoker 395 (87.4) 57 (12.6)  
Ex-smoker 799 (85.9) 131 (14.1)  
Current-smoker 577 (83.1) 117 (16.9)  
Stress   < 0.001 
  BEPSI < 1.8 1,302 (91.4) 123 (8.6)  
BEPSI: 1.8 - 2.8 443 (74.3) 153 (25.7)  
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 BEPSI ≥ 2.8  26 (47.3)  29 (52.7)  
Anxiety   < 0.001 
  GAS score < 3 1,064 (95.4) 51 (4.6)  
  GAS score ≥ 3  707 (73.6) 254 (26.4)  
Depression   < 0.001 
  GDS score < 2 731 (97.1) 22 (2.9)  
  GDS score ≥ 2 1,040 (78.6) 283 (21.4)  
Physical Activity   0.211 
  Low 200 (82.0)  44 (18.0)  
  Moderate 638 (85.0) 113 (15.0)  
  High 933 (86.3) 148 (13.7)  
Snoring    0.029 
  < 3 times/week 1,426 (86.2) 229 (13.8)  
 ≥ 3 times/week 345 (82.0) 76 (18.0)  
Antihypertensives   0.481 
Yes  374 (86.4)  59 (13.6)  
 No 1,397 (85.0) 246 (15.0)   
*P values were obtained by t-test or chi-square test. Values are mean ± standard 
deviation or number (%). 
† Sub-category of job: Group 1 (professional/office job) / Group 2 (service/sales job) / 
Group 3 (agriculture/fishing/blue collar job) / Group 4 (housewife/no job) / Group 5 
(etc.) Sub-category of job; ‡ Sub-category of income: Group 1 ( <400 KRW / month) / 
Group 2 (400 - 600 KRW / month) / Group 3 (600 - 800 KRW / month) / Group 4 ( ≥ 
800 KRW / month).  
BEPSI refers to Brief Encounter Psychosocial Instrument, GAS refers to Goldberg 
Anxiety Scale, GDS refers to Goldberg Depression Scale, IPAQ refers to the 









Among females, low sleep quality was associated with age (p = 0.007), 
education (p = 0.002), income (p = 0.004), smoking (p = 0.027), stress (p < 
0.001), anxiety (p < 0.001), depression (p < 0.001), snoring (p < 0.001), use of 
































Table 1B. Baseline characteristics of the subjects among females (n = 981). 
 Good sleeper 
global PSQI ≤ 5 
(n = 757) 
Poor sleeper 
global PSQI > 5 
(n = 224) 
 
P-value* 
Age (y) 48.59 ± 12.81 51.27 ± 13.87 0.007 
Marriage status   0.307 
  Yes 210 (75.0) 70 (25.0)  
  No 547 (78.0) 154 (22.0)  
Education   0.002 
< High School 107 (69.0) 48 (31.0)  
High School Graduate 211 (73.8) 75 (26.2)  
> High School   439 (81.3) 101 (18.7)  
Job†   0.202 
Group 1 116 (80.0) 29 (20.0)  
Group 2 108 (83.7) 21 (16.3)  
Group 3  74 (72.6) 28 (27.4)  
Group 4 419 (76.2) 131 (23.8)  
Group 5 40 (72.7) 15 (27.3)  
Income‡   0.004 
Group1 259 (71.0) 106 (29.0)  
Group2 273 (79.8) 69 (20.2)  
Group3 158 (81.4) 36 (18.6)  
Alcohol use   0.196 
None 421 (75.9) 134 (24.1)  
Past 56 (72.7) 21 (27.3)  
Current 280 (80.2) 69 (19.8)  
Smoking   0.027 
Non-smoker 701 (78.2) 195 (21.8)  
Ex-smoker 31 (68.9) 14 (31.1)  
Current-smoker 25 (62.5) 15 (37.50)  
Stress   < 0.001 
  BEPSI < 1.8 518 (85.6) 87 (14.4)  
BEPSI: 1.8 - 2.8 212 (68.4) 98 (31.6)  
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 BEPSI ≥ 2.8 27 (40.9) 39 (59.1)  
Anxiety   < 0.001 
  GAS score < 3 363 (93.6) 25 (6.4)  
  GAS score ≥ 3 394 (66.4) 199 (33.6)  
Depression   < 0.001 
  GDS score < 2 215 (93.5) 15 (6.5)  
  GDS score ≥ 2 542 (72.2) 209 (27.8)  
Physical Activity   0.989 
  Low 103 (77.4) 30 (22.6)  
  Moderate 141 (77.5) 41 (22.5)  
  High 513 (77.0) 153 (23.0)  
Snoring    < 0.001 
  < 3 times/week 681 (79.2) 179 (20.8)  
  ≥ 3 times/week 76 (62.8) 45 (37.2)  
Antihypertensives   < 0.001 
 Yes 96 (63.6) 55 (36.4)  
No 661 (79.6) 169 (20.4)  
Menopausal status   0.009 
  Premenopausal 320 (81.8) 71 (18.2)  
Menopausal transition 62 (83.8) 12 (16.2)  
Menopausal 316 (73.7) 113 (26.3)  
*P values were obtained by t-test or chi-square test. Values are mean ± standard 
deviation or number (%). 
† Sub-category of job: Group 1 (professional/office job) / Group 2 (service/sales job) / 
Group 3 (agriculture/fishing/blue collar job) / Group 4 (housewife/no job) / Group 5 
(etc.) Sub-category of job; ‡ Sub-category of income: Group 1 ( <400 KRW / month) / 
Group 2 (400 - 600 KRW / month) / Group 3 (600 - 800 KRW / month) / Group 4 ( ≥ 
800 KRW / month).  
BEPSI refers to Brief Encounter Psychosocial Instrument, GAS refers to Goldberg 
Anxiety Scale, GDS refers to Goldberg Depression Scale, IPAQ refers to the 





In men, the presence of metabolic syndrome was related to smoking (p < 
0.001), physical activity (p = 0.009), snoring (p < 0.001) and use of 

































Table 1C. Baseline characteristics of the subjects among males (n = 2,076). 
  Metabolic syndrome 
Yes (n = 560)     No (n = 1,516) 
P-value* 
Age (y) 51.31 ± 12.15 52.26 ± 11.25 0.107 
Marriage status   0.209 
  Yes 50 (23.4) 164 (76.6)  
  No 510 (27.4) 1,352 (72.6)  
Education   0.646 
< High School  44 (27.9) 114 (72.1)  
High School Graduate 126 (28.6) 315 (71.4)  
> High School 390 (26.4) 1,087 (73.6)  
Job†   0.637 
Group 1 160 (26.0) 456 (74.0)  
Group 2 124 (26.4) 345 (73.6)  
Group 3 160 (29.3) 387 (70.7)  
Group 4 60 (24.7) 183 (75.3)  
Group 5 56 (27.9) 145 (72.1)  
Income‡   0.591 
Group 1 172 (28.5) 431 (71.5)  
Group 2 223 (26.2) 629 (73.8)  
Group 3 146 (26.6) 403 (73.4)  
Alcohol use   0.270 
None 68 (23.8) 218 (76.2)  
Past 35 (24.1) 110 (75.9)  
Current 457 (27.8) 1,188 (72.2)  
Smoking   < 0.001 
Non-smoker  91 (20.1) 361 (79.9)  
Ex-smoker 254 (27.3) 676 (72.7)  
Current-smoker 215 (31.0) 479 (69.0)  
Stress   0.164 
  BEPSI < 1.8 381 (26.7) 1,044 (73.3)  
BEPSI: 1.8 - 2.8 158 (26.5)  438 (73.5)  
 BEPSI ≥ 2.8 21 (38.2)  34 (61.8)  
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Anxiety   0.243 
  GAS score < 3 289 (25.9) 826 (74.1)  
  GAS score ≥ 3 271 (28.2) 690 (71.8)  
Depression   0.146 
  GDS score < 2 189 (25.1) 564 (74.9)  
  GDS score ≥ 2 371 (28.0) 952 (72.0)  
Physical Activity   0.009 
  Low 82 (33.6) 162 (66.4)  
  Moderate 213 (28.4) 538 (71.6)  
  High 265 (24.5) 816 (75.5)  
Snoring    < 0.001 
  < 3 times/week 400 (24.2) 1,255 (75.8)  
 ≥ 3 times/week 160 (38.0)  261 (62.0)  
Antihypertensives   < 0.001 
 Yes 195 (45.0) 238 (55.0)  
No 365 (22.2) 1,278 (77.8)  
*P values were obtained by t-test or chi-square test. Values are mean ± standard 
deviation or number (%). 
† Sub-category of job: Group 1 (professional/office job) / Group 2 (service/sales job) / 
Group 3 (agriculture/fishing/blue collar job) / Group 4 (housewife/no job) / Group 5 
(etc.) Sub-category of job; ‡ Sub-category of income: Group 1 ( <400 KRW / month) / 
Group 2 (400 - 600 KRW / month) / Group 3 (600 - 800 KRW / month) / Group 4 ( ≥ 
800 KRW / month).  
BEPSI refers to Brief Encounter Psychosocial Instrument, GAS refers to Goldberg 
Anxiety Scale, GDS refers to Goldberg Depression Scale, IPAQ refers to the 










In women, the presence of metabolic syndrome was associated with age (p < 
0.001), education (p < 0.001), job (p = 0.008), income (p < 0.001), snoring (p 
< 0.001), use of hypertensive drugs (p < 0.001) and menopausal status (p < 
0.001) positively. However, the presence of metabolic syndrome was related to 































Table 1D. Baseline characteristics of the subjects among females (n = 981). 
 Metabolic syndrome 
Yes (n = 98)     No (n = 883) 
P-value* 
Age (y)  58.47 ± 1.03  48.17 ± 12.98 < 0.001 
Marriage status   0.100 
  Yes 21 (7.50) 259 (92.50)  
  No 77 (11.0) 624 (89.0)  
Education   < 0.001 
< High School 32 (20.7) 123 (79.3)  
High School Graduate 34 (11.9) 252 (88.1)  
> High School 32 (5.9) 508 (94.1)  
Job†   0.008 
Group 1 6 (4.1) 139 (95.9)  
Group 2 6 (4.6) 123 (95.4)  
Group 3 14 (13.7) 88 (86.3)  
Group 4 66 (12.0) 484 (88.0)  
Group 5 6 (10.9) 49 (89.1)  
Income‡   < 0.001 
Group1 55 (15.1) 310 (84.9)  
Group2 29 (8.5) 313 (91.5)  
Group3 9 (4.6) 185 (95.4)  
Alcohol use   0.001 
None 72 (13.0) 483 (87.0)  
Past 7 (9.1) 70 (90.9)  
Current 19 (5.4) 330 (94.6)  
Smoking   0.636 
Non-smoker 92 (10.3) 804 (89.7)  
Ex-smoker 3 (6.7)  42 (93.3)  
Current-smoker 3 (7.5)  37 (92.5)  
Stress   0.283 
  BEPSI < 1.8 61 (10.1) 544 (89.9)  
BEPSI: 1.8 - 2.8 27 (8.7) 283 (91.3)  
 BEPSI ≥ 2.8 10 (15.2) 56 (84.8)  
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Anxiety   0.115 
  GAS score < 3 46 (11.9) 342 (88.1)  
  GAS score ≥ 3 52 (8.8) 541 (91.2)  
Depression   0.023 
  GDS score < 2 32 (13.9) 198 (86.1)  
  GDS score ≥ 2 66 (8.8) 685 (91.2)  
Physical Activity   0.730 
  Low 12 (9.0) 121 (91.0)  
  Moderate 16 (8.8) 166 (91.2)  
  High 70 (10.5) 596 (89.5)  
Snoring    < 0.001 
  < 3 times/week 74 (8.6) 786 (91.4)  
  ≥ 3 times/week 24 (19.8) 97 (80.2)  
Antihypertensives   < 0.001 
 Yes 44 (29.1) 107 (70.9)  
No 54 (6.5) 776 (93.5)  
Menopausal status   < 0.001 
  Premenopausal 13 (3.3) 378 (96.7)  
Menopausal transition 2 (2.7) 72 (97.3)  
Menopausal 65 (15.2) 364 (84.8)  
*P values were obtained by t-test or chi-square test. Values are mean ± standard 
deviation or number (%). 
† Sub-category of job: Group 1 (professional/office job) / Group 2 (service/sales job) / 
Group 3 (agriculture/fishing/blue collar job) / Group 4 (housewife/no job) / Group 5 
(etc.) Sub-category of job; ‡ Sub-category of income: Group 1 ( <400 KRW / month) / 
Group 2 (400 - 600 KRW / month) / Group 3 (600 - 800 KRW / month) / Group 4 ( ≥ 
800 KRW / month).  
BEPSI refers to Brief Encounter Psychosocial Instrument, GAS refers to Goldberg 
Anxiety Scale, GDS refers to Goldberg Depression Scale, IPAQ refers to the 





There was no significant difference in clinical characteristics between good 
sleepers and poor sleepers in men. Subgroup analysis showed that sleep quality 

































Table 2A. Comparisons of clinical characteristics between good sleepers and 
poor sleepers among males. 
Variables Good sleepers Poor sleepers P-value* 
Main group (n = 2,076)    
N  1,771 (85.3) 305 (14.7)  
BMI (kg/m2) 24.20 ± 2.79 24.26 ± 2.91 0.705 
WC (cm) 88.40 ± 7.90 88.64 ± 8.45 0.614 
FBS (mg/dL) 94.64 ± 19.21  95.94 ± 20.82 0.283 
SBP (mmHg) 127.25 ± 14.11 126.80 ± 13.78 0.610 
DBP (mmHg) 77.41 ± 10.35  77.86 ± 10.57 0.486 
TG (mg/dL) 132.93 ± 82.03 141.39 ± 97.19 0.106 
HDL-C (mg/dL) 50.53 ± 12.06  51.99 ± 12.10 0.052 
Metabolic syndrome 470 (26.5) 90 (29.5) 0.280 
Subgroup ( n = 635)    
N 554 (87.2) 81 (12.8)  
VAT (cm2) 110.04 ± 24.52  111.71 ± 28.68  0.576 
SAT (cm2) 114.42 ± 21.98 115.96 ± 27.50 0.570 
Insulin (μIU/mL) 6.81 ± 3.98  7.35 ± 5.13 0.275 
HOMA 1.64 ± 1.06    1.83 ± 1.37 0.150 
*P values were obtained by t-test or chi-square test. Values are mean ± standard 
deviation or number (%). BMI: body mass index, WC: waist circumference, FBS: 
fasting blood sugar, SBP: systolic blood pressure, DBP: diastolic blood pressure, TG: 
triglyceride, HDL-C: high density lipoprotein cholesterol, VAT: visceral adipose tissue, 
SAT: subcutaneous adipose tissue. HOMA refers to homeostasis model assessment, a 










However, body mass index (p < 0.001), waist circumference (p < 0.001), 
fasting blood sugar (p = 0.006), diastolic blood pressure (p = 0.036) and systolic 
blood pressure (p = 0.017) were related to poor sleepers group positively among 
females. Though there was a trend that poor sleepers group was related to VAT, 































Table 2B. Comparisons of clinical characteristics between good sleepers and 
poor sleepers among females. 
Variables Good sleepers Poor sleepers P-value* 
Main group (n = 981)    
N  757 (77.2) 224 (22.8)  
BMI (kg/m2) 22.37 ± 3.30 23.43 ± 3.34  < 0.001 
WC (cm) 7 9.13 ± 9.26 83.16 ± 9.71 < 0.001 
FBS (mg/dL)  88.73 ± 14.58  91.99 ± 18.43  0.006 
SBP (mmHg) 119.59 ± 16.37 122.56 ± 16.26 0.017 
DBP (mmHg)  72.18 ± 10.92 73.93 ± 11.20 0.036 
TG (mg/dL) 94.32 ± 48.21 100.29 ± 52.32 0.111 
HDL-C (mg/dL) 60.82 ± 13.69 59.26 ± 13.80 0.136 
Metabolic syndrome 68 (9.0) 30 (13.4) 0.053 
Subgroup ( n = 209 )    
N 150 (71.8) 59 (28.2)  
VAT (cm2) 89.18 ± 22.88 94.77 ± 22.89 0.113 
SAT (cm2) 131.68 ± 26.58 138.42 ± 23.73 0.091 
Insulin (μIU/mL) 5.99 ± 3.25 6.52 ± 4.54 0.347 
HOMA 1.36 ± 0.87 1.47 ± 1.16 0.459 
*P values were obtained by t-test or chi-square test. Values are mean ± standard 
deviation or number (%). BMI: body mass index, WC: waist circumference, FBS: 
fasting blood sugar, SBP: systolic blood pressure, DBP: diastolic blood pressure, TG: 
triglyceride, HDL-C: high density lipoprotein cholesterol, VAT: visceral adipose tissue, 
SAT: subcutaneous adipose tissue. HOMA refers to homeostasis model assessment, a 









The PSQI global sleep-quality score was not associated significantly with the 
presence of the metabolic syndrome. Particularly, odds ratio of metabolic 
syndrome relating to poor sleep quality (OR = 1.07, 95% CI: 0.79 - 1.44 for 
males; OR = 1.16, 95% CI: 0.66 – 2.02 for females) decreased relatively, after 
controlling for age, education, alcohol, smoking, stress, anxiety, depression, 






























Table 3. Results of logistic regression relating the metabolic syndrome to the 
PSQI global sleep quality score. 
 Model 1 Model 2 Model 3 
 cOR 95% CI aOR 95% CI aOR 95% CI 
Male       
Sleep quality 1.16 0.89 - 1.51 1.18 0.90 - 1.54 1.07 0.79 - 1.44 
Female       
Sleep quality 1.57 0.99 - 2.48 1.29 0.80 - 2.08 1.16 0.66 - 2.02 
cOR = crude OR. 
aOR = adjusted OR. 
CI = confidence interval. 
Model 1, unadjusted. 
Model 2, adjusted for age. 
Model 3, adjusted for age, education, alcohol, smoking, stress, anxiety, depression, 





















Poor sleep quality was not associated with most metabolic syndrome 
component risk factors in men and women. Subgroup analysis showed that 
global sleep quality was not related significantly to VAT, SAT and insulin 
resistance. However, poor sleep quality was related to high-density lipoprotein 
(p = 0.014) positively among males, and the predictor of waist circumference 
(p < 0.001) and body mass index (p = 0.009) gain among females (Table 4A 





























Table 4A. Multiple regression results relating aspects of the metabolic 
syndrome to the PSQI global sleep quality score among males (n = 2,076). 
 PSQI Global Sleep Quality Index 
Variable β SE t P-value 
Main group (n = 2,076)     
WC (cm) -0.08 0.51 -0.15 0.884 
FBS (mg/dL) < 0.01 < 0.01 1.54 0.124 
SBP (mmHg) -0.29 0.90 -0.32 0.752 
DBP (mmHg) 0.41 0.68 0.61 0.542 
TG (mg/dL) < 0.01 < 0.01 0.18 0.858 
HDL-C (mg/dL) 0.04 0.01 2.45 0.014 
BMI (kg/m2) -0.30 0.18 -0.17 0.868 
Subgroup ( n = 635)     
VAT (cm2) 0.35 3.14 0.11 0.912 
SAT (cm2) 0.64 2.84 0.23 0.821 
HOMA < 0.01 0.09 0.03 0.979 
Adjusted for age, education, alcohol, smoking, stress, anxiety, depression, physical 
activity, snoring and use of hypertensive drugs. 
WC: waist circumference, FBS: fasting blood sugar, SBP: systolic blood pressure, DB
P: diastolic blood pressure, TG: triglyceride, HDL-
C: high density lipoprotein cholesterol, BMI: body mass index, VAT: visceral adipose 
tissue, SAT: subcutaneous adipose tissue. HOMA refers to homeostasis model assess













Table 4B. Multiple regression results relating aspects of the metabolic 
syndrome to the PSQI global sleep quality score among females (n = 981). 
 PSQI Global Sleep Quality Index 
Variable β SE t P-value 
Main group (n = 981)     
WC (cm) 2.74 0.69 3.97 < 0.001 
FBS (mg/dL) < 0.01 < 0.01 0.36 0.715 
SBP (mmHg) 0.99 1.22 0.81 0.417 
DBP (mmHg) 0.52 0.88 0.59 0.558 
TG (mg/dL) > -0.01  < 0.01 -0.87 0.386 
HDL-C (mg/dL) > -0.01  0.02 -0.22 0.828 
BMI (kg/m2) 0.67 0.26 2.61 0.009 
Subgroup ( n = 209)     
VAT (cm2) 3.07 3.53 0.87 0.387 
SAT (cm2) 3.94 4.30 0.92 0.360 
HOMA -0.05 0.12 -0.42 0.677 
Adjusted for age, education, alcohol, smoking, stress, anxiety, depression, physical 
activity, snoring and use of hypertensive drugs. 
WC: waist circumference, FBS: fasting blood sugar, SBP: systolic blood pressure, DBP: 
diastolic blood pressure, TG: triglyceride, HDL-C: high density lipoprotein cholesterol, 
BMI: body mass index, VAT: visceral adipose tissue, SAT: subcutaneous adipose tissue. 











In our analyses of data from aged from 30-81, generally healthy adults, the 
global sleep quality score, as measured by the PSQI, was not related 
significantly to the metabolic syndrome. However, J. Richard showed that an 
increase in the global PSQI score of 2.6 points is associated with a 44% risk of 
having metabolic syndrome after adjusting for age and gender in Caucasian 
adults (14). Although J. Richard found positive relationships between global 
PSQI score and fasting plasma glucose, waist circumference, and BMI, their 
sample is relatively small. Hung and colleagues show that subjects with 
metabolic syndrome have a significantly higher global PSQI score, and that the 
presence of metabolic syndrome is associated with a 0.9 increase in this (15). 
Their results show that hyperglycemia and low HDL-C were independently 
associated factors of the global PSQI score, and low HDL-C was the only 
independent predictor of being a poor sleeper. Unfortunately, they did not 
consider insulin resistance and abdominal visceral fat which are both vital 
factors to metabolic syndrome.  
The mechanism underlying the association between metabolic syndrome and 
sleep quality remains unclear. Hypothalamicpituitary-adrenal (HPA) 
hyperactivity plays a role in the pathogenesis of the metabolic syndrome (33) 
and activation of the HPA axis can lead to sleeplessness (34). In addition, 
several short term studies show that sleep fragmentation or restriction lead to 
insulin resistance (10,12,17,35) which appears to play a key role in the 
pathophysiology of metabolic syndrome (36). Indeed, chronic sleep debt may 
have modulatory effects on the glucose metabolism and promote the 
development of the metabolic syndrome, resulting in sleep disorders which in 
turn lead to poor sleep quality (37). 
This is the first epidemiologic study to investigate the relationship between 
CT measured abdominal adiposity with self-reported sleep quality in a large 
sample. Our study is unique in its use of precise measures of abdominal fat 
areas by CT, fasting blood samples of insulin, metabolic syndrome components 
which are strongly associated with each other, to explore the relationship of 
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sleep quality and metabolic disorders using the PSQI. In our study, sleep quality 
and duration were not appreciably associated with VAT. S Yi’ study also found 
that there is no association between VAT and sleep duration (38). However, in 
Kim’s study, which is cross-sectional, short sleep duration is associated with 
VAT (39). 
We found metabolic syndrome and most of its components were not related 
to the PSQI global score, which is inconsistent with J. Richard’s and Hung’s 
studies (14, 15). However, our study found that poor sleep quality was 
positively associated with HDL-C in male, and the predictor of waist 
circumference and BMI gain in female. In Choi’s cohort study, the mean HDL 
levels of participants sleeping less than 6 hours a day were higher than those of 
participants sleeping 6 to 7.9 and 8 to 9.9 hours a day in men, which was similar 
with our results (40). Furthermore participants sleeping less than 6 hours had 
the lowest TG levels compared to the other groups in men. However, Choi and 
colleagues did only consider sleep duration other than sleep quality in the study, 
and did not consider mental health such as stress, depression and anxiety. 
Regarding to increasing waist circumference and BMI among women because 
of low sleep quality in our research, Cecilia BJ Örkelund's prospective 
population study gives us a strong support, which found that there is no 
association between sleep problems and developing diabetes was seen in this 
32-year follow-up of middle-aged women. Their results showed that obesity, 
on the other hand, known to cause increased risk of diabetes, was associated 
with current sleep problems (20).  
The results, that PSQI global sleep-quality score was not significantly 
associated with VAT and insulin resistance, which are more biologically valid 
markers of metabolic disorders, may support the result strongly that sleep 
quality was not related to metabolic syndrome and its component risk factors 
in our study. In addition, our post-hoc power among males was 0.85 and the 
power among women was 0.69. However, the post-hoc for all subjects in our 
study, which of an uncorrected chi-squared statistic was also not significant (p 
= 0.475), was 0.97. The power analysis can support our null hypothesis strongly 
that the prevalence of metabolic syndrome between good sleepers group and 
poor sleepers group is equal. 
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There are several limitations in the present study. First, since this work is 
cross-sectional in nature, the causal relationship between metabolic disorders 
and sleep quality score could not be established. Secondly, we did not measure 
sleep by objective means, such as actigraphy and polysomnography. 
Furthermore, the PSQI is not related to objective measures of sleep, such as 
wrist actigraphy and polysomnography, in African Americans (41). Thirdly, we 
did not exclude the unrecognized confounding variables such as obstructive 
sleep apnea (OSA) and a few medications (e.g. antipsychotic drugs, 
glucocorticoids).  
In conclusion, self-reported global sleep quality is not significantly related to 
metabolic syndrome and most its components. However, obesity is associated 
with poor sleep quality in women. Finally, identification of the proximal 
behavioral and biologic relationships between sleep and components of the 
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서론: 수면의 질과 대사증후군과의 관계에 대한 연구는 미미한 실
정으로 본 논문에서는 Pittsburgh Sleep Quality Scale (PSQI)을 이
용하여 평가한 수면의 질과 대사증후군과의 관계를 알아보고자 하
였다. 
 
방법: 단면조사로 수행된 연구로서 수면의 질과 대사증후군지표와
의 관계를 알아보자고 하였다. 2010년 1월부터 2011년 12월까지 
서울대학교병원 가정의학과 건강증진센터에 내원한 나이가 18-80
세의 3,057 명 (남자 2,076명, 여자 981명)을 대상으로 하였다. 
이 대상자 중 대사증후군의 유병율은 21.5% (남자 27.0%, 여자 
10.0%)였다. PSQI 총점에 따라 불만족스러운 수면군 (n = 529)과 
만족스러운 수면군 (n = 2,528), 두 군으로 분류하였으며 수면의 
질과 복부비만, 인슐린 저항성, 대사증후군지표와의 관계를 분석하
였다. 대사증후군지표 측정, 인슐린 측정, 복부비만 CT (컴퓨터 촬영)
을 실행하였다. 대사증후군은 2005년 AHA/NHLBI 에서 제시한 진
단기준에 따라 정의하였다. 모든 통계분석은 나이, 교육수준, 음주, 
흡연, 스트레스, 불안, 우울, 신체활동, 코골기, 고혈압약물 복용에 
대해 보정하였다. 
 
결과: 로지스틱회귀분석에서는 수면의 질과 대사증후군의 관계는 
유의한 결과를 보이지 않았다 (남자 OR = 1.07, 95% CI: 0.79 - 
1.44; 여자 OR = 1.16, 95% CI: 0.66 – 2.02). 그리고 선형회귀분
석에서도 수면의 질과 복부 내장비만, 인슐린, 인슐린 저항성, 대부
분 대사증후군 지표들과의 관계는 유의하지 않았다. 다만 남자에서
는 불면증과 HDL-콜레스테롤 (p = 0.014)은 양의 상관관계를 보였
으나, 여자에서는 불면증과 허리둘레 (p < 0.001) 또는 체질량 지수
는 (p = 0.009) 양의 상관관계를 보였다. 
 
결론: 수면의 질과 대사증후군과의 관계는 유의하지 않다. 다만 여
자에서는 수면의 질과 비만과의 관련성은 있다. 향후 수면장애 집단
38 
 
을 대상으로 수면의 질을 향상시키는 중재 프로그램이 대사증후군
에 미치는 효과에 관한 전향적인 코호트 연구가 필요할 것으로 여
겨진다. 
------------------------------------- 
주요어: 대사증후군, 수면의 질, 복부비만, 인슐린 저항성, 
Pittsburgh sleep quality index 
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